The short version of lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-20 and is reviewed periodically as new material appears.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
== Name == When the state was established in 1992 following the breakup of the Socialist Federal Republic of Yugoslavia (SFR Yugoslavia), it adopted the official name Federal Republic of Yugoslavia (FR Yugoslavia) and claimed to continue the international legal personality and United Nations membership of the SFR Yugoslavia. This claim was not accepted by the United Nations. Security Council Resolution 777 determined that the SFR Yugoslavia had ceased to exist and that the FR Yugoslavia could not automatically continue its United Nations membership, which was regarded as belonging to the now-defunct SFR Yugoslavia. General Assembly Resolution 47/1 consequently required the FR Yugoslavia to apply for membership and barred it from participating in the work of the General Assembly. The FR Yugoslavia applied for membership in 2000 and was admitted to the United Nations as a new member on 1 November under General Assembly Resolution 55/12. In 2003, the country was reconstituted as the State Union of Serbia and Montenegro, which continued the Federal Republic's international legal personality without controversy.
=== In adult stem cells === Ferroptosis has emerged as a significant regulator of adult stem cell maintenance and tissue regeneration. In human hematopoietic stem cells (HSCs), a naturally low rate of protein synthesis creates a selective vulnerability to ferroptosis; key protective factors such as GPX4, SLC7A11, and ferritin are insufficiently produced, and blocking ferroptosis fully rescues HSC maintenance even without restoring protein synthesis rates. In muscle stem cells (MuSCs), age-related chronic inflammation drives an epigenetic erosion of the histone mark H4K20me1 by downregulating its methyltransferase Kmt5a. This leads to the transcriptional silencing of anti-ferroptotic genes, including Gpx4, Ftl1, and Gclc, resulting in intracellular iron accumulation, lipid peroxidation, and ferroptotic death of MuSCs. The resulting depletion of the MuSC pool impairs muscle regeneration and contributes to age-related sarcopenia. Long-term pharmacological inhibition of systemic inflammation or restoration of the Kmt5a–H4K20me1 axis has been shown to prevent MuSC ferroptosis and improve regenerative capacity in aged muscle tissue.
==== Lorcaserin ==== Lorcaserin is the only agent that has completed phase III clinical trials, and achieved US Food and Drug Administration (FDA) approval. However it was later withdrawn from the market in February 2020 due to a higher risk of malignancy in a randomized trial of lorcaserin. Previously approved agents were subsequently removed from the US market. Lorcaserin is a full agonist for 5-HT2C and 5-HT2B receptors and partial agonist for 5-HT2A receptors (75% of the maximal response elicited by serotonin). Lorcaserin is a potent and selective 5-HT2C agonist with rapid oral absorption that shows dose-dependent decrease in food intake and body weight. Lorcaserin affects body weight by producing a negative energy balance through reduced food intake (energy intake) without alterations in energy expenditure and substrate oxidation. Lorcaserin has a high affinity for the 5-HT2C receptors, with 18-fold selectivity over 5-HT2A receptors and 104-fold over 5-HT2B receptors. The predicted blood concentration to stimulate 2A and 2B receptors is approximately 1400-fold for 2B and 250-fold for 2A, above the blood concentration that is required to stimulate the 2C receptors. This functional selectivity is critical to prevent potential side effects and suggests that the theoretical risk of cardiac valvulopathy is very low. Clinical trials have supported this theory since they have not revealed any side effects on heart valves or pulmonary artery pressure like the former obesity drugs.
the first technological developments were a thinner-gauge device-shell, and a filler gel of low-cohesion silicone, which improved the functionality and the verisimilitude (size, appearance, and texture) of the silicone-gel breast implant. Yet, in clinical practice, second-generation breast implants proved fragile and saw greater instances of shell rupture, and of filler leakage ("silicone-gel bleed") through the intact device shell. The consequent, increased incidence-rates of medical complications (e.g. capsular contracture) precipitated faulty-product, class action-lawsuits, by the U.S. government, against the Dow Corning Corporation, and other manufacturers of breast prostheses. the second technological development was a polyurethane foam coating for the shell of the breast implant; the coating reduced the incidence of capsular contracture, by causing an inflammatory reaction that impeded the formation of a capsule of fibrous collagen tissue around the breast implant. Nevertheless, despite that prophylactic measure, the medical use of polyurethane-coated breast implants was briefly discontinued, because of the potential health-risk posed by 2,4-toluenediamine (TDA), a carcinogenic by-product of the chemical breakdown of the polyurethane foam coating of the breast implant proven to cause liver and skin cancers in animal-model studies. After reviewing the medical data, the U.S.
Sources: en.wikipedia.org
Gochujang or red chili paste is a savory, sweet, and spicy fermented condiment popular in Korean cooking. It is made from gochugaru (red chili powder), chapssal (glutinous rice), meju (fermented soybean) powder, yeotgireum (barley malt powder), and salt. The sweetness comes from the starch of cooked glutinous rice, cultured with saccharifying enzymes during the fermentation process. Traditionally, it would be naturally fermented over years in jangdok (earthenware) on an elevated stone platform called jangdokdae in the backyard.
=== Modification of diet in renal disease (MDRD) formula === Another formula for calculating the GFR is the one developed by the Modification of Diet in Renal Disease Study Group. Most laboratories in Australia, and the United Kingdom calculate and report the estimated GFR along with creatinine measurements and this forms the basis of diagnosis of chronic kidney disease. The adoption of the automatic reporting of MDRD-eGFR has been widely criticised. The most commonly used formula is the "4-variable MDRD", which estimates GFR using four variables: serum creatinine, age, ethnicity, and gender. The original MDRD used six variables with the additional variables being the blood urea nitrogen and albumin levels. The equations have been validated in patients with chronic kidney disease; however, both versions underestimate the GFR in healthy patients with GFRs over 60 mL/min. The equations have not been validated in acute renal failure. For creatinine in μmol/L:
An amputee patient in a southern Gazan hospital stated that medication comes through the crossing into Gaza every four days but its not a guarantee that patients receive medication, and that in some hospitals patients have to pay for medication and food up front. Other medications such as insulin pens were temporarily placed on restricted items to be allowed into Gaza by the Israeli government officials. This caused the UN Humanitarian Coordinator for Palestine Jamie McGoldrick to state; "On the goods that are being prohibited, it’s a full range...Some of it is medical material such as basic drugs and material for treating not just trauma but for chronic illnesses...One example would be most recently the pens that are used for insulin for children" A Canadian doctor returning from two weeks in Gaza stated he had seen the "sickest child I had ever seen in my medical career". By July 2024, children in tent camps were infected with a number of skin diseases. By the summer of 2025, Gaza's healthcare system had been sharply curtailed, with most hospitals in Gaza damaged or out of service. This makes it impossible to access even basic care and leads to growing obstacles for those in need of specialized treatment and support. The humanitarian consequences fall especially hard on children.
Sources: en.wikipedia.org
The Islamabad Talks, also known as the Islamabad Peace Talks, were held in Islamabad, Pakistan, on 11 and 12 April 2026. Aimed at stabilizing the 2026 Iran war ceasefire and negotiating a potential resolution to the war, the talks were moderated by Pakistan, which played a central role in brokering the ceasefire and facilitating the talks. The 300-member U.S. negotiating team was led by Vice President JD Vance, alongside special envoys Steve Witkoff and Jared Kushner; while the 70-member Iranian team was led by parliamentary speaker Mohammad Bagher Ghalibaf, alongside foreign minister Abbas Araghchi. The Pakistani mediating team was led by prime minister Shehbaz Sharif, field marshal Asim Munir, and deputy prime minister and foreign minister Ishaq Dar. The talks lasted 21 hours between 11 and 12 April 2026, and consisted of three rounds with the first one being indirect and the second and third ones being direct. The day of the meeting, Trump told reporters that he did not care about whether an agreement would come out of the talks. The teams were reportedly able to agree on the main points of the 10-points ceasefire, with the exception of the issues regarding the Strait of Hormuz and the Iranian nuclear program. The talks ended with no agreement reached, and no memorandum of understanding (MoU) being issued. Following the failure of the talks, U.S. president Donald Trump imposed a naval blockade on Iran on 13 April, interdicting any ships entering or departing Iranian ports.
== Inclusion of disorders == Newborn screening programs initially used screening criteria based largely on criteria established by JMG Wilson and F. Jungner in 1968. Although not specifically about newborn population screening programs, their publication, Principles and practice of screening for disease proposed ten criteria that screening programs should meet before being used as a public health measure. Newborn screening programs are administered in each jurisdiction, with additions and removals from the panel typically reviewed by a panel of experts. The four criteria from the publication that were relied upon when making decisions for early newborn screening programs were:
== History == 4-HO-DPT was first described in the scientific literature by David Repke and colleagues in 1977. Subsequently, it was described in further detail by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). The drug was encountered as a novel designer drug in Europe in 2012.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.